17,936 followers
A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naïve, high-risk essential thrombocythemia as a primary treatment https://t.co/d2EwJhcDpW https://t.co/6IjsNMnd2y
A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naïve, high-risk essential thrombocythemia as a primary treatment https://t.co/d2EwJhcDpW https://t.co/6IjsNMnd2y
New research: A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naïve, high-risk essential thrombocythemia as a primary treatment: As the discussion of first-line anagrelide treatment is… https://t.